Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials
Authors
Keywords
-
Journal
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume 29, Issue 5, Pages 441-449
Publisher
Informa UK Limited
Online
2017-11-03
DOI
10.1080/09546634.2017.1395806
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report
- (2018) L. Thorlacius et al. BRITISH JOURNAL OF DERMATOLOGY
- Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy
- (2017) Barry Moran et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Adalimumab efficacy in hidradenitis suppurativa patients is sustained at least three years with weekly dosing: Results from a phase 3 open-label extension study (PIONEER)
- (2017) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients
- (2017) Patrizia Weber et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Recommendations for the management of comorbidity in hidradenitis suppurativa
- (2017) E. Dauden et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa
- (2017) D. Jiménez-Gallo et al. MEDIATORS OF INFLAMMATION
- The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases
- (2017) Taku Kuwabara et al. MEDIATORS OF INFLAMMATION
- Quality of life considerations and pain management in hidradenitis suppurativa
- (2017) Gregor Jemec SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Pathophysiology of hidradenitis suppurativa
- (2017) Lauren Hoffman et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum
- (2016) J.L. Blok et al. BRITISH JOURNAL OF DERMATOLOGY
- Interferon-gamma (IFN-γ) is Elevated in Wound Exudate from Hidradenitis Suppurativa
- (2016) Anirban Banerjee et al. IMMUNOLOGICAL INVESTIGATIONS
- Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study
- (2016) Inge E. Deckers et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Antibodies to watch in 2017
- (2016) Janice M. Reichert mAbs
- MMP8 Is Increased in Lesions and Blood of Acne Inversa Patients: A Potential Link to Skin Destruction and Metabolic Alterations
- (2016) Athanasia Tsaousi et al. MEDIATORS OF INFLAMMATION
- Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
- (2016) Alexa B. Kimball et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa
- (2016) Vassiliki Tzanetakou et al. JAMA Dermatology
- Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients
- (2015) G. Shalom et al. BRITISH JOURNAL OF DERMATOLOGY
- An Update on Medical Treatment Options for Hidradenitis Suppurativa
- (2015) I. E. Deckers et al. DRUGS
- Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: a possible metabolic loop
- (2015) G. Monfrecola et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
- (2015) A.B. Kimball et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Ethnicity and Hidradenitis Suppurativa
- (2014) Virginia J. Reeder et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Interleukin 17A: Toward a new understanding of psoriasis pathogenesis
- (2014) Charles W. Lynde et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Role of insulin resistance and diet in acne
- (2013) Rashmi Kumari et al. Indian Journal of Dermatology Venereology & Leprology
- Impaired Notch signalling: the unifying mechanism explaining the pathogenesis of hidradenitis suppurativa (acne inversa)
- (2012) B.C. Melnik et al. BRITISH JOURNAL OF DERMATOLOGY
- Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments
- (2012) Hessel H. van der Zee et al. EXPERIMENTAL DERMATOLOGY
- Incidence of Hidradenitis Suppurativa and Associated Factors: A Population-Based Study of Olmsted County, Minnesota
- (2012) Benjamin G. Vazquez et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Hidradenitis Suppurativa
- (2011) Brigitte Dr éno ARCHIVES OF DERMATOLOGY
- Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
- (2011) H.H. van der Zee et al. BRITISH JOURNAL OF DERMATOLOGY
- Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
- (2011) Christoph Schlapbach et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa
- (2011) W.P. Gulliver et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Treatment of Hidradenitis Suppurativa With Etanercept Injection
- (2010) David R. Adams et al. ARCHIVES OF DERMATOLOGY
- Deficiency of IL-22 Contributes to a Chronic Inflammatory Disease: Pathogenetic Mechanisms in Acne Inversa
- (2010) K. Wolk et al. JOURNAL OF IMMUNOLOGY
- Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial
- (2010) Annika Grant et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited
- (2009) Katia Boniface et al. IMMUNOLOGICAL REVIEWS
- Non-psoriatic dermatologic uses of monoclonal antibody therapy
- (2009) Mary E. Sockolov et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Efalizumab discontinuation: A practical strategy
- (2009) Rupa Pugashetti et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa
- (2009) Robert A. Lee et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started